PT2444078T - Utilização de amidas de ácidos mono e dicarboxílicos no tratamento de doenças renais - Google Patents

Utilização de amidas de ácidos mono e dicarboxílicos no tratamento de doenças renais

Info

Publication number
PT2444078T
PT2444078T PT104253190T PT10425319T PT2444078T PT 2444078 T PT2444078 T PT 2444078T PT 104253190 T PT104253190 T PT 104253190T PT 10425319 T PT10425319 T PT 10425319T PT 2444078 T PT2444078 T PT 2444078T
Authority
PT
Portugal
Prior art keywords
amides
mono
treatment
dicarboxylic acids
renal diseases
Prior art date
Application number
PT104253190T
Other languages
English (en)
Inventor
Federica Della Valle Maria
Della Valle Francesco
Migliaccio Raffaele
Original Assignee
Epitech Group S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitech Group S P A filed Critical Epitech Group S P A
Publication of PT2444078T publication Critical patent/PT2444078T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT104253190T 2010-10-04 2010-10-04 Utilização de amidas de ácidos mono e dicarboxílicos no tratamento de doenças renais PT2444078T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10425319.0A EP2444078B1 (en) 2010-10-04 2010-10-04 Use of amides of mono and dicarboxylic acids in the treatment of renal diseases

Publications (1)

Publication Number Publication Date
PT2444078T true PT2444078T (pt) 2017-11-15

Family

ID=43569937

Family Applications (1)

Application Number Title Priority Date Filing Date
PT104253190T PT2444078T (pt) 2010-10-04 2010-10-04 Utilização de amidas de ácidos mono e dicarboxílicos no tratamento de doenças renais

Country Status (7)

Country Link
US (2) US20120083533A1 (pt)
EP (1) EP2444078B1 (pt)
JP (2) JP6462198B2 (pt)
CN (1) CN102526006B (pt)
BR (1) BRPI1107261A2 (pt)
ES (1) ES2648051T3 (pt)
PT (1) PT2444078T (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2444078B1 (en) * 2010-10-04 2017-09-13 EPITECH GROUP S.p.A. Use of amides of mono and dicarboxylic acids in the treatment of renal diseases
ITMI20131132A1 (it) * 2013-07-05 2015-01-06 Epitech Group Srl Uso in combinazione di amidi di acidi mono- e dicarbossilici e silimarina nel trattamento di patologie renali
PT2921171T (pt) * 2014-03-21 2020-01-21 Epitech Group S P A Preparações oftálmicas, intra-articulares ou intravesicais contendo n-acil-etanolaminas
EP2985037B1 (en) * 2014-08-13 2017-06-21 EPITECH GROUP S.p.A. A pharmaceutical composition comprising palmitoylethanolamid and cytidine-diphosphocholine
DK3215143T3 (da) * 2014-10-22 2021-09-20 Again Life Italia Srl Kombination omfattende spirulina og palmitoylethanolamid
SG10201807034XA (en) * 2017-09-05 2019-04-29 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618842A (en) 1991-12-31 1997-04-08 Lifegroup S.P.A. N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin
DK1207870T3 (da) 1999-08-06 2005-08-01 Innovet Italia Srl Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
AU2003208761A1 (en) * 2002-02-21 2003-09-09 Amarin Development Ab A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use
US20080103209A1 (en) * 2004-04-23 2008-05-01 The Regents Of The University Of California Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists
EP1844784B1 (en) * 2006-03-28 2010-04-21 Epitech Group S.r.l. A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
WO2007124169A2 (en) * 2006-04-21 2007-11-01 The Board Of Trustees Operating Michigan State University Compositions and methods for transient receptor potential vanilloid (trpv) channel mediated treatments
WO2008023998A1 (en) * 2006-08-22 2008-02-28 Industrial Research Limited N-acylethanolamines as wound healing agents
NZ552238A (en) * 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
CA2761156C (en) * 2009-05-07 2017-03-14 University Of Cincinnati Methods of preventing ischemic injury using peripheral nociceptive stimulation
EP2444078B1 (en) * 2010-10-04 2017-09-13 EPITECH GROUP S.p.A. Use of amides of mono and dicarboxylic acids in the treatment of renal diseases

Also Published As

Publication number Publication date
ES2648051T3 (es) 2017-12-28
US20120083533A1 (en) 2012-04-05
JP2012077084A (ja) 2012-04-19
EP2444078B1 (en) 2017-09-13
EP2444078A1 (en) 2012-04-25
JP6462198B2 (ja) 2019-01-30
US20150065576A1 (en) 2015-03-05
BRPI1107261A2 (pt) 2013-07-30
CN102526006A (zh) 2012-07-04
JP2017128578A (ja) 2017-07-27
CN102526006B (zh) 2016-12-21
US9402818B2 (en) 2016-08-02

Similar Documents

Publication Publication Date Title
GB2478595B (en) Phytocannabinoids in the treatment of glioma
HK1201740A1 (en) Aptamers to -ngf and their use in treating -ngf mediated diseases and disorders -ngf -ngf
HK1192879A1 (zh) 取代的 -苄基環烷基羧酸及其用途
PT3042910T (pt) 2'-espiro-nucleósidos para utilização na terapia da hepatite c
IL222006A (en) Pyrulobenzodiazepine conjugates and their use in medicine
EP2521447A4 (en) FATTY FATTY ACID DERIVATIVES AND USES THEREOF
IL248880B (en) Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases
IL221874A (en) History of pyrimidine and their use in the treatment of respiratory diseases such as copd
EP2432462A4 (en) OXYGEN PROCEDURE AND COMPOSITIONS FOR THE TREATMENT OF MAMMALIAN DISEASES
HK1180322A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
PT2291394T (pt) Proteínas de fusão e seus usos no diagnóstico e tratamento de leishmaniose
GB201120993D0 (en) Novel compounds and their use in therapy
IL231374A (en) Use of epa and dha to treat eye disease
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
EP2542266A4 (en) 4-1BB-BINDING APTAMERS AND USE THEREOF IN THE TREATMENT OF DISEASES AND DISORDERS
PT2444078T (pt) Utilização de amidas de ácidos mono e dicarboxílicos no tratamento de doenças renais
EP2651894A4 (en) THIOSEMICARBAZONE COMPOUNDS FOR CANCER TREATMENT
EP2817304A4 (en) NOVEL COMPOUNDS AND THEIR THERAPEUTIC USE
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
ZA201305266B (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
EP2596062A4 (en) LIVING RADICAL POLYMERIZATION (LRP) WITH SINGLE-ELECTRO-TRANSFER (SET) OF ACRYLATES IN THE PRESENCE OF ACIDS
PL2648715T3 (pl) Mieszaniny karnozyny-kwasu hialuronowego i ich zastosowanie
PL2614824T3 (pl) Pochodna triazolowa do stosowania w leczeniu bólu neuropatycznego i fibromialgii
HK1203430A1 (en) Bisarylsulfonamides useful in the treatment of inflammation and cancer
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER